Brief: Alligator Bioscience Q2 EBIT Loss at SEK 63.7 Million
13/07/2023 07:02
Jul 13 (Reuters) - Alligator Bioscience Q2 adjusted EPS SEK -0.19. * Q2 revenue SEK 17.4 million * Q2 EBIT SEK -63.7 million * Q2 net income SEK -63.7 million
Recent news on Alligator Bioscience AB
See all newsSweden's Alligator Bioscience Q3 sales fall as R&D winds down
Brief: Alligator Bioscience Q3 EBIT SEK -19.3 Million
Brief: Alligator Bioscience Appoints Johan Gileus As CEO
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience To Initially Receive SEK 58.8 Mln From Rights Issue